主页 /
搜索结果：“akt”

“akt”的搜索结果

Quick View
LY3023414

Catalog No. A16126
Quick View

添加到收藏
PI3K/mTOR Dual 抑制剂

LY3023414是从专利WO/2012097039A1（化合物实施例1）中提取的I类PI3K同种型，mTOR和DNA-PK的口服ATP竞争性抑制剂，对Akt1（pT308）的IC50为64.9 nM，42.1 nM，10.6 nM和19.1 nM。），Akt1（pS473），P70S6（pT389），S6RP（pS240/242）。了解更多

Product Citations (1)

Bulk Inquiry
- Zou Y, .et al. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo, Biochem Biophys Res Commun, 2017, Aug 19;490(2):385-392 PMID: 28623128
Quick View
Tenalisib (RP6530)

Catalog No. A16799
Quick View

添加到收藏
dual PI3Kδ/γ 抑制剂

Tenalisib (RP6530)是一种有效且选择性的双重PI3Kδ/PI3Kγ抑制剂，能抑制B细胞淋巴瘤细胞系的生长，同时降低下游生物标记物pAKT。了解更多

Bulk Inquiry
Quick View
Miltefosine

Catalog No. A14138
Quick View

添加到收藏
PI3K/Akt 抑制剂

Miltefosine在癌细胞系A431和HeLa中抑制PI3K/Akt活性，ED50为17.2μM和8.1μM。了解更多

Bulk Inquiry
Quick View
alpha-Bisabolol

Catalog No. A18691
Quick View

添加到收藏
alpha-Bisabolol is a nontoxic sesquiterpene alcohol present in natural essential oil, with anticancer activity. alpha-Bisabolol exerts selective anticancer effect on A549 NSCLC cells (IC50=15 μM) via induction of cell cycle arrest, mitochondrial apoptosis and inhibition of PI3K/Akt signalling pathways. alpha-Bisabolol also strongly induces apoptosis in glioma cells. 了解更多

Bulk Inquiry
Quick View
Rigosertib sodium

Catalog No. A21824
Quick View

添加到收藏
multi-kinase inhibitor

Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 了解更多

Bulk Inquiry
Quick View
OSU-T315

Catalog No. A20870
Quick View

添加到收藏
ILK inhibitor

OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). 了解更多

Bulk Inquiry
Quick View
YS-49

Catalog No. A21198
Quick View

添加到收藏
PI3K/Akt activator

YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. 了解更多

Bulk Inquiry